Sanford Health Selects Translational Software for Large-Scale Expansion of Pharmacogenomics Program to Individualize Patient Care

BELLEVUE, Wash.– Translational Software®, Inc. (TSI), a leader in the intelligent use of genetic data for clinical decision support and precision medicine, announced that Sanford Health, a Dakotas-based non-profit health system, and one of the largest integrated health systems in the nation, has selected TSI’s pharmacogenomics (PGx) knowledge base and PGx platform to expand its genomics program across multiple U.S. regions to personalize patient treatment and improve health outcomes throughout the Sanford Health enterprise.

“We are pleased that our new FHIR-based API technology architecture will provide a scalable PGx solution at Sanford Health. Ensuring integrated PGx results reporting, and making PGx data more accessible and less expensive, is a key element toward democratizing genomic medicine.”

Tweet this

Sanford Imagenetics is a comprehensive genomic medicine initiative launched in 2014 that aims to fully integrate the tools of genomic medicine into primary care for adults. This u

< | >